8-KFinancial EventsExhibits & Filings

Archer-Daniels-Midland Co 8-K Report, Exit or Disposal Costs (Jan 13, 2012)

Filed January 13, 2012For Securities:ADM

Summary

Archer-Daniels-Midland Company (ADM) filed a Form 8-K on January 13, 2012, reporting two significant events. First, on January 11, 2012, the company committed to a planned reduction in its salaried workforce, indicating that the associated pre-tax charges will result in future cash expenditures. This action suggests a strategic move to streamline operations and potentially improve efficiency. Second, on January 9, 2012, ADM determined that it would take an impairment charge related to its commercial alliance with Metabolix, Inc. and its joint venture, Telles, LLC. This impairment is a consequence of changes in circumstances and specific actions taken by ADM concerning this venture, implying a re-evaluation of the partnership's value or future prospects. Investors should monitor any further disclosures regarding the financial impact of these workforce reductions and the Metabolix venture.

Key Highlights

  • 1ADM announced a planned reduction in its salaried workforce, effective January 11, 2012.
  • 2The workforce reduction is expected to result in pre-tax charges with future cash expenditures.
  • 3ADM identified a need for an impairment charge related to its commercial alliance with Metabolix, Inc. and its joint venture, Telles, LLC.
  • 4The impairment charge stems from changes in circumstances and specific actions impacting the Metabolix venture.
  • 5The filing date for this Form 8-K is January 13, 2012, with the earliest event reported on January 9, 2012.

Frequently Asked Questions

The Form 8-K filing addresses two main events: a planned reduction in ADM's salaried workforce and an impairment charge related to its joint venture with Metabolix, Inc. (Telles, LLC).

The workforce reduction will result in pre-tax charges. ADM has indicated that these charges are expected to lead to future cash expenditures, suggesting a cost-saving measure that will incur immediate expenses but aims for long-term benefits.

The impairment charge is due to a change in circumstances and specific actions taken by ADM that have negatively impacted its commercial alliance and joint venture (Telles, LLC) with Metabolix, Inc. This indicates a reassessment of the value or future viability of this partnership.

The decision impacting the Metabolix venture occurred on January 9, 2012, and the commitment to reduce the salaried workforce was made on January 11, 2012. The filing date of the report is January 13, 2012.